Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel
Cannabis Law Report
AUGUST 31, 2021
Canonic’s first product line, G-nnovation, is based on cannabis varieties that were selected and developed to express high levels of THC[1] and premium consumer traits. With this, Canonic has completed its end-to-end cannabis value chain in Israel , from seed to product. Full commercial product launch in Israel is expected in 2022.
Let's personalize your content